26 May 2013
Keywords: gilead, recruits, ph, iii, elvitegravir, hiv, trial
Article | 04 August 2008
California, USA-based Gilead Sciences has started the enrollment of patients in a Phase III clinical trial of elvitegravir, an
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 August 2008
24 May 2013
© 2013 thepharmaletter.com